{"symbol": "SYN", "companyName": "Synthetic Biologics Inc.", "exchange": "NYSE American", "industry": "Biotechnology", "website": "http://www.syntheticbiologics.com", "description": "Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.", "CEO": "Steven A. Shallcross", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}